abstract |
A method for the treatment of osteoporosis, Paget's ndisease of bone, hyperparathyroidism, malignant neoplasms ncausing hypercalcinemia, parodontal diseases and implant-related nbone loss comprising administration to a patient sufferÂning therefrom an amount of a compound of the formula (I), nor a prodrug or a pharmaceutically acceptable salt thereof. |